| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10611869808997881 |
| P698 | PubMed publication ID | 9769021 |
| P2093 | author name string | George J | |
| Lee T | |||
| Park E | |||
| Putney SD | |||
| Starzyk RM | |||
| McGrath JP | |||
| Lynch P | |||
| Schutz AJ | |||
| P2860 | cites work | Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate | Q42525170 |
| Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier | Q44785157 | ||
| Transferrin and iron uptake by the brain: effects of altered iron status | Q45562653 | ||
| Bifunctional fusion between nerve growth factor and a transferrin receptor antibody | Q48055027 | ||
| Transferrin receptor on endothelium of brain capillaries | Q48602638 | ||
| Transport of [125I]transferrin through the rat blood-brain barrier | Q57677412 | ||
| Human transferrin: cDNA characterization and chromosomal localization | Q24596395 | ||
| New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor | Q27656280 | ||
| Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes | Q27860600 | ||
| Receptor-mediated transcytosis of transferrin across the blood-brain barrier | Q28303216 | ||
| Signal-dependent membrane protein trafficking in the endocytic pathway | Q29622948 | ||
| NGF in CNS: experimental data and clinical implications | Q30886123 | ||
| Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting | Q33685694 | ||
| Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex | Q33827984 | ||
| Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate | Q34058435 | ||
| Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery | Q34060172 | ||
| Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. | Q34061528 | ||
| Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo | Q34239620 | ||
| Transferrin-antibody fusion proteins are effective in brain targeting | Q34506062 | ||
| Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease | Q35761924 | ||
| The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor | Q35884401 | ||
| Recombinant Toxins for Cancer Treatment | Q36533609 | ||
| Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections | Q36936476 | ||
| Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes | Q37093959 | ||
| Transcytotic pathway for blood-borne protein through the blood-brain barrier | Q37484109 | ||
| Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier | Q37521936 | ||
| Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases | Q38715616 | ||
| Trophic factors and neuronal survival | Q38772889 | ||
| The nerve growth factor 35 years later | Q39667849 | ||
| Folding and association of proteins | Q39696106 | ||
| Human beta-nerve growth factor gene sequence highly homologous to that of mouse | Q40236820 | ||
| Structural determinants of neurotrophin action. | Q40468353 | ||
| Receptor blockade with monoclonal antibodies as anti-cancer therapy | Q40585866 | ||
| Gene therapy in the central nervous system: direct versus indirect gene delivery | Q40959820 | ||
| Transport and elimination of recombinant human NGF during long-term delivery to the brain | Q41184267 | ||
| Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth | Q41316837 | ||
| Nerve growth factor in Alzheimer's disease: to treat or not to treat? | Q41330754 | ||
| High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein. | Q41436201 | ||
| Rapid endocytosis of the transferrin receptor in the absence of bound transferrin | Q41467499 | ||
| Blood-brain barrier penetration and in vivo activity of an NGF conjugate | Q41578400 | ||
| Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation | Q41596156 | ||
| Nerve growth factor: structure/function relationships | Q41956129 | ||
| Sustained Release of Nerve Growth Factor from Biodegradable Polymer Microspheres | Q42461657 | ||
| Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. | Q42519480 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 53-64 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Journal of Drug Targeting | Q6295099 |
| P1476 | title | Production and characterization of fusion proteins containing transferrin and nerve growth factor | |
| P478 | volume | 6 |
| Q38088357 | Advances and challenges in developing cytokine fusion proteins as improved therapeutics |
| Q34019876 | Endogenous carriers and ligands in non-immunogenic site-specific drug delivery |
| Q38798702 | Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration |
| Q43093968 | In vitro characterization of an acetylcholine receptor-transferrin fusion protein for the treatment of myasthenia gravis |
| Q39918619 | Insertion of the designed helical linker led to increased expression of tf-based fusion proteins |
| Q91801425 | Microwave Assisted Sol-Gel Synthesis of Silica-Spider Silk Composites |
| Q35172436 | New systems for delivery of drugs to the brain in neurological disease |
| Q24548071 | Novel nanocomposites from spider silk-silica fusion (chimeric) proteins |
| Q33713530 | Recombinant proteins for genetic disease. |
Search more.